Alcohol and Prostate Cancer: What You Need to Know

Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health.
Alcohol is part of many people’s social lives, whether it’s a glass of wine with dinner or a beer while watching the football game. But if you’re paying close attention to your prostate health, you might wonder whether drinking alcohol could increase your risk of prostate cancer. Or if you’re getting treatment for prostate cancer, you may be asking if it’s okay to drink.
Alcohol and Prostate Cancer Risk
How Alcohol May Affect Prostate Cancer Risk
The research results don’t all line up, but there’s enough evidence to suggest that drinking in moderation or limiting alcohol intake is a reasonable way to help protect yourself, says Dr. Helfand.
Drinking Alcohol During Prostate Cancer Treatment
One question you might have if you’ve been diagnosed with prostate cancer is whether alcohol can interfere with treatment. Here’s how alcohol can affect prostate cancer treatment and recovery.
Surgery
Drinking alcohol, especially with heavy or regular use, can increase the risk of complications after prostate cancer surgery, says Taub.
He says that people who drink alcohol before surgery face higher rates of:
- Infections
- Wound-healing problems
- Breathing troubles
- Long hospital stays
Drinking alcohol can also worsen urinary symptoms like urgency, frequency, and stress incontinence, says Helfand. These symptoms are already common if you have prostate cancer or an enlarged prostate. Many men report that stress incontinence gets noticeably worse after having two or more drinks during the recovery period after surgery, he says.
Chemotherapy
Radiation Therapy
Targeted Therapy and Immunotherapy
Taub emphasizes that people getting cancer treatment who drink alcohol face increased risks of the cancer coming back, developing new cancers, and dying from the disease. Both experts agree that limiting or avoiding alcohol before, during, and after prostate cancer treatment can help your body heal better and may improve treatment success.
Alcohol and PSA Levels
“Lower PSA levels in drinkers may reduce the sensitivity of PSA-based prostate cancer screening, potentially delaying diagnosis or underestimating risk,” says Taub. Because current guidelines don’t list alcohol as a factor that may affect PSA interpretation, it’s important to mention your drinking habits to your healthcare provider when discussing PSA results.
How Much Alcohol Is Safe?
Helfand recommends drinking in moderation or completely avoiding alcohol for most people. Men at higher risk of prostate cancer, such as those with a family history of prostate cancer or genetic mutations like BRCA2, should be especially careful and consider abstaining from alcohol altogether, he says.
If you or someone you know is struggling with substance use, reach out to the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-HELP (4357) for resources near you.
The Takeaway
- There’s a link between heavy or long-term drinking and a higher risk of aggressive prostate cancer, though more research is needed.
- Alcohol can interfere with prostate cancer treatment and recovery, making surgery, chemotherapy, radiation, or targeted therapy less effective, with potentially worse side effects.
- Drinking may also lower PSA levels, which can make prostate cancer harder to detect. Be sure to tell your healthcare provider about your drinking habits when reviewing test results.
- The safest choice for prostate health is to avoid alcohol or limit it to no more than two drinks per day, especially if you’re at higher risk or you’re currently getting prostate cancer treatment.
Resources We Trust
- Cleveland Clinic: The Sobering Truth: How Alcohol Affects Cancer Risk
- Mayo Clinic: Alcohol and Cancer Risk
- Centers for Disease Control and Prevention: Alcohol and Cancer
- Baptist Health: Alcohol Consumption and Prostate Cancer
- Roswell Park Comprehensive Cancer Center: Does Alcohol Affect PSA Level?
- Kaltsas A et al. To Drink or Not to Drink? Investigating Alcohol’s Impact on Prostate Cancer Risk. Cancers. October 12, 2024.
- Macke AJ et al. Alcohol and Prostate Cancer: Time to Draw Conclusions. Biomolecules. February 28, 2022.
- Leitão C et al. The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers. Journal of Clinical Medicine. May 22, 2022.
- Understanding Alcohol Drinking Patterns. National Institute on Alcohol Abuse and Alcoholism. February 2025.
- What Is A Standard Drink? National Institute on Alcohol Abuse and Alcoholism. December 2024.
- Hong SE et al. Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis. Nutrients. July 23, 2020.
- Alcohol Metabolism. National Institute on Alcohol Abuse and Alcoholism. June 2025.
- Elahy V et al. Adherence to American Cancer Society Guideline and Mortality in Men With Nonmetastatic Prostate Cancer. JAMA Network Open. September 26, 2025.
- Medical Complications: Common Alcohol-Related Concerns. National Institute on Alcohol Abuse and Alcoholism. May 8, 2025.
- Ortolá R et al. Alcohol Consumption Patterns and Mortality Among Older Adults With Health-Related or Socioeconomic Risk Factors. JAMA Network Open . August 12, 2024.
- Alcohol Use and Cancer. American Cancer Society. November 3, 2025.
- Zhao L et al. Alcohol Use During Chemotherapy: A Pilot Study. Wisconsin Medical Journal. July 2022.
- Fountoukidis G et al. Effect of Alcohol Consumption on Oncological Treatment Effectiveness and Toxicity in Patients With Cancer: A Systematic Review and Meta-Analysis. BMC Cancer. February 12, 2025.
- Prostate-Specific Antigen (PSA) Test. National Cancer Institute. January 31, 2025.
- No Level of Alcohol Consumption Is Safe for Our Health. World Health Organization. January 4, 2023.
- Alcohol and Cancer Risk. National Cancer Institute. May 2, 2025.
- Survivorship Care for Healthy Living. NCCN Guidelines for Patients. March 29, 2024.
- Sobriety and Alcohol-Free Options. Baptist Health. March 18, 2025.

Tawee Tanvetyanon
Medical Reviewer
Tawee Tanvetyanon, MD, MPH, is a professor of oncologic sciences and senior member at H. Lee Moffitt Cancer Center and Morsani College of Medicine at the University of South Florida in Tampa. He is a practicing medical oncologist specializing in lung cancer, thymic malignancy, and mesothelioma.
A physician manager of lung cancer screening program, he also serves as a faculty panelist for NCCN (National Comprehensive Cancer Network) guidelines in non-small cell lung cancer, mesothelioma, thymoma, and smoking cessation. To date, he has authored or coauthored over 100 biomedical publications indexed by Pubmed.

Maggie Aime, MSN, RN
Author
Maggie Aime is a registered nurse with over 25 years of healthcare experience, who brings medical topics to life through informative and inspiring content. Her extensive nursing background spans specialties like oncology, cardiology, and pediatrics. She has also worked in case management, revenue management, medical coding, and as a utilization review nurse consultant. She leverages her unique insights to help individuals navigate the U.S. healthcare system and avoid financial pitfalls.
Maggie applies her extensive clinical expertise to create empowering education for readers at all stages. She is passionate about illuminating issues from disease prevention to health and wellness to medical personal finance. Her work can be found in GoodRx Health, Next Avenue, HealthNews, Insider, Nursing CE Central, Nurse Blake, AllNurses, and BioHackers Lab.
An active member of several professional nursing and journalism associations, Maggie founded The Write RN to fulfill her calling to teach.
When she's not crafting the next great article, you can find Maggie volunteering, reading, playing the piano, or savoring sunrise views at the beach.